In this study, we found that estrogen-induced DNMT1 increased the DNA methylation of TP53 to repress p53 expression, which positively affected DNMT1 expression, thus promoting poor prognosis of lung cancer by modulating EMT and the microenvironment. This evidence concerns the gene DNMT1 and lung carcinoma.